Validation of an algorithm for identifying MS cases in administrative health claims datasets
Date
2019Journal
NeurologyPublisher
Lippincott Williams and WilkinsType
Article
Metadata
Show full item recordAbstract
Objective: To develop a valid algorithm for identifying multiple sclerosis (MS) cases in administrative health claims (AHC) datasets. Methods: We used 4 AHC datasets from the Veterans Administration (VA), Kaiser Permanente Southern California (KPSC), Manitoba (Canada), and Saskatchewan (Canada). In the VA, KPSC, and Manitoba, we tested the performance of candidate algorithms based on inpatient, outpatient, and disease-modifying therapy (DMT) claims compared to medical records review using sensitivity, specificity, positive and negative predictive values, and interrater reliability (Youden J statistic) both overall and stratified by sex and age. In Saskatchewan, we tested the algorithms in a cohort randomly selected from the general population. Results: The preferred algorithm required ≥3 MS-related claims from any combination of inpatient, outpatient, or DMT claims within a 1-year time period; a 2-year time period provided little gain in performance. Algorithms including DMT claims performed better than those that did not. Sensitivity (86.6%–96.0%), specificity (66.7%–99.0%), positive predictive value (95.4%–99.0%), and interrater reliability (Youden J = 0.60–0.92) were generally stable across datasets and across strata. Some variation in performance in the stratified analyses was observed but largely reflected changes in the composition of the strata. In Saskatchewan, the preferred algorithm had a sensitivity of 96%, specificity of 99%, positive predictive value of 99%, and negative predictive value of 96%. Conclusions: The performance of each algorithm was remarkably consistent across datasets. The preferred algorithm required ≥3 MS-related claims from any combination of inpatient, outpatient, or DMT use within 1 year. We recommend this algorithm as the standard AHC case definition for MS.Identifier to cite or link to this item
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062393622&doi=10.1212%2fWNL.0000000000007043&partnerID=40&md5=93eaa969db43545ee5716b84181b28c4; http://hdl.handle.net/10713/10816ae974a485f413a2113503eed53cd6c53
10.1212/WNL.0000000000007043
Scopus Count
Collections
Related articles
- Validation of an algorithm to detect severe MS relapses in administrative health databases.
- Authors: Marriott JJ, Chen H, Fransoo R, Marrie RA
- Issue date: 2018 Jan
- The prevalence of MS in the United States: A population-based estimate using health claims data.
- Authors: Wallin MT, Culpepper WJ, Campbell JD, Nelson LM, Langer-Gould A, Marrie RA, Cutter GR, Kaye WE, Wagner L, Tremlett H, Buka SL, Dilokthornsakul P, Topol B, Chen LH, LaRocca NG, US Multiple Sclerosis Prevalence Workgroup.
- Issue date: 2019 Mar 5
- Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study.
- Authors: Al-Sakran L, Marrie RA, Blackburn D, Knox K, Evans C
- Issue date: 2019 Nov 25
- The rising prevalence and changing age distribution of multiple sclerosis in Manitoba.
- Authors: Marrie RA, Yu N, Blanchard J, Leung S, Elliott L
- Issue date: 2010 Feb 9
- Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan.
- Authors: Al-Sakran LH, Marrie RA, Blackburn DF, Knox KB, Evans CD
- Issue date: 2018 May